MedTrace Logo

Screening and Treating Asymptomatic Bacteriuria Every Trimester and Preterm Birth

NCT03274960 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 480

Last updated 2023-05-11

No results posted yet for this study

Summary

This study is evaluating whether screening of a pregnant woman for asymptomatic bacteriuria in each trimester for early detection and treatment of bacteriuria will reduce the incidence of preterm birth in Harare.

Conditions

Interventions

COMBINATION_PRODUCT

Griess,

Experimental: Griess, Culture and antibiotic Griess reagents, sulfanilamide and NED added in urine sample for 20 minutes, urine culture using blood agar for 24 hours and treatment with antibiotic every trimester for up to 7 days.

Sponsors & Collaborators

  • University of Zimbabwe

    lead OTHER

Principal Investigators

  • Muchabaiwa F Gidiri, MD · Senior Lecturer, Chairperson Obstetrics and Gynecology Department, University of Zimbabwe

  • Pasipanodya Nziramasamga, PHD · Senior Lecturer, Medical Microbiology Department, University of Zimbabwe

  • Babil Stray- Pedersen, Professor · Doctor, Medisin Department, Oslo University

  • Clara Haruzivishe, PHD · Senior lecturer, Department of Nursing Science, University of Zimbabwe

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-23
Primary Completion
2020-01-30
Completion
2020-12-30

Countries

  • Zimbabwe

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03274960 on ClinicalTrials.gov